“Next Generation Silver Technology: Enhancing Silver to Address Wound Bioburden
Event Navigation
ConvaTec* & Wound Source Webinars present…“Next Generation Silver Technology: Enhancing Silver to Address Wound Bioburden”
Despite advances in wound management technologies, the problem of chronic non-healing wounds continues. Chronic wounds negatively impact patients’ quality of life and add significantly to treatment costs and costs associated with potential related litigation. A recent economic analysis of more than 8 million wounds in seniors estimated annual costs approaching $10 billion.
Several factors contribute to wound chronicity, but wound infection and persistant bioburden continue to emerge as playing key roles. Innovative approaches are necessary to overcome these challenges.
Advanced and proven technologies that address the challenge of wound bioburden should be considered as front line treatment to avoid development of wound recalcitrance.
This program introduces a new and innovative wound dressing intervention to effectively manage wound recalcitrance due to persistent bioburden.
Registrants attending this session will learn:
- Distinctions between microorganism tolerance and antimicrobial resistance
- Factors contributing to wound chronicity
- Importance of early and aggressive wound management
- Strategies for effective management of persistent wound bioburden
Presenters:
Catherine T. Milne, APRN, MSN, ANP/ACNS-BC, CWOCN-AP | Co-Owner | Connecticut Clinical Nursing Associates
Jennifer Hurlow, GNP-BC, CWCN | Geriatric Nurse Practitioner | Wound, Ostomy, Continence Nurse
It does not appear that continuing education credit is available for this session.
Questions should be addressed by WoundSource.com or your ConvaTec representative.
* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
